Dew Drops CBD

01/09/2026

CBD / Cannabis Potential To Protect & Treat Traumatic Brain Injury

✔️ Study Overview

• Preclinical research investigated the effects of cannabidiol on traumatic brain injury

• Focused on cognitive recovery and cellular mechanisms underlying brain protection

• Identified a previously unrecognized molecular pathway involved in neuronal survival

✔️ Key Findings

• Cannabidiol significantly improved learning and memory performance after traumatic brain injury

• Treatment reduced neuronal cell death in brain regions critical for cognition

• Oxidative stress markers were markedly decreased following cannabidiol administration

✔️ Newly Identified Mechanism

• Cannabidiol directly binds to a cellular protein called SET

• This interaction alters the shape and location of SET within neurons

• SET is retained in the cytoplasm rather than entering the nucleus

• This modulation influences PP2A signaling and promotes activation of the Akt survival pathway

• The mechanism operates independently of the classical PI3K pathway

✔️ Why This Matters

• Traumatic brain injury has limited effective treatments for cognitive impairment

• Secondary injury processes such as oxidative stress and programmed cell death drive long term damage

• Cannabidiol targets these secondary processes rather than the initial mechanical injury

✔️ Neuroprotective Effects of Cannabidiol

• Supports neuronal survival under stress conditions

• Reduces oxidative damage that contributes to progressive brain injury

• Engages endogenous cell survival signaling pathways

✔️ Safety and Translational Context

• Cannabidiol has an established safety profile in humans for other medical indications

• It is non intoxicating and does not produce THC associated psychoactive effects

• Findings are based on animal models and require validation in human clinical trials

✔️ Clinical and Research Implications

• Identifies SET and related signaling pathways as potential therapeutic targets

• Supports further investigation of cannabidiol as a treatment for traumatic brain injury

• Highlights the importance of timing and dosing in future clinical studies

This study provides a clear molecular foundation for cannabidiol CBD as a promising candidate in Protecting and Treating traumatic brain injury research.

Stay Ahead With Most Recent Research Summaries on Beneficial Botanicals/Fungi

Learn With Us ⬇️ Join Us / GCL Here
Green Culture Labs co., Ltd

For Educational Purposes Only.
Viewer Discretion Advised.

January 3, 2026
Link 🔗 to Study / Source in First Comments Below ⬇️

01/07/2026

NEWS
You Might Have Missed

01/07/2026

Rheumatoid arthritis (RA) is more than joint pain - it is an immune-driven inflammatory condition where the body attacks its own joint lining, causing swelling, stiffness, and persistent pain. When inflammation stays high, sleep suffers, movement shrinks, and many patients cycle through medications that help some, but rarely reset the core imbalance. This is where the cannabinoid conversation gets interesting, not because of hype, but because of biology.

CBG, CBD, and THC are showing up in patient stories and early clinical observations as meaningful tools for relief. Each works differently, but together they can complement the goal: supporting the ECS, our Master Regulator, toward equilibrium.

CBD acts as an inflammation modulator. It interacts with serotonin receptors linked to mood and pain perception, influences TRPV1 channels involved in tissue irritation, and may slow the breakdown of internal lipids, such as anandamide. For many patients, consistent CBD use has led to reduced stiffness, calmer pain signaling, and improved mobility, especially when paired with hydration and baseline medical care.

CBG brings a quieter, but potent angle. It has shown anti-inflammatory effects in cellular models, influencing pathways tied to immune balance without suppressing immune function entirely. Patients often describe reduced joint swelling, less aggressive flare intensity, and more functional comfort when CBG-rich products are added into their routine.

THC works more directly. It engages CB1 receptors in the brain and immune tissues, softening pain circuits tied to the amygdala, reducing inflammatory feedback loops, and supporting a better sleep rhythm that RA often disrupts. Low-to-moderate THC use for many consumers has meant fewer overnight pain spikes, improved rest, and less morning stiffness waiting at the door.

The collective effect is not about sedation - it is about regulation. Many patients report that combined cannabinoid protocols help them rely less on steroids, carry less NSAID load, and move through daily tasks with less resistance. Every ECS baseline is different, so dosing and timing vary, but the stories carry a common rhythm: less stiffness, more movement, fewer spikes, and more comfort in the body they live in.

The real value isn’t one cannabinoid doing everything - it is synergy, timing awareness, hydration support, and restoring balance at the Master Regulator level. That is how patients with RA are finding relief, reclaiming movement, reclaiming sleep, and steering the system back toward regulatory calm, instead of living in the flare-pain-repeat loop.

-Mike Robinson, The Researcher OG

01/07/2026

Cannabis compounds may hold promise against one of the deadliest cancers: ovarian cancer. 🌿🧬

Recent lab research shows that cannabinoids like CBD and THC don’t just slow cancer cell growth — they also interfere with the cells’ ability to spread, a key factor in metastasis. Ovarian cancer is especially dangerous because it often spreads silently before symptoms appear.

Researchers observed that cannabinoids disrupt cell communication pathways involved in migration and invasion. Instead of allowing cancer cells to cluster, multiply, and expand, these compounds weaken their structural organization, limiting the formation of new growth sites.

Important note: these effects were seen in controlled lab studies, not in human patients. Still, the findings open new doors for research. If cancer spread can be slowed, cannabinoids could one day support conventional treatments like chemotherapy or targeted therapy.

This is not a cure or a replacement for medical treatment, but it highlights how plant-derived compounds may help target cancer in ways traditional drugs often cannot. 🌱

01/04/2026

You can still place your orders, just please leave your name and number, and I will get back within 24 hours.
Also we have some BIG changes coming very soon.
Look for the BIG announcement!!!!
812-725-2547

Jan. & Feb. 2025 ALL oils are buy 1 get the for 1/2 off.
Please call the 812-725-2547 or your welcome to text.

We hope you all had a wonderful Christmas and Very
Happy New Year!!!

01/04/2026

https://www.facebook.com/share/p/17bQC4pxjC/

Scientists are beginning to uncover how compounds in cannabis may influence one of the most aggressive forms of cancer—ovarian cancer. In recent laboratory research, cannabinoids like CBD and THC didn’t just slow the growth of cancer cells—they interfered with the cells’ ability to spread and form new colonies, a key driver of metastasis.

Ovarian cancer is particularly dangerous because it often spreads silently before symptoms appear. What makes these findings notable is that cannabinoids disrupted cell communication pathways involved in migration and invasion. Instead of allowing cancer cells to cluster, multiply, and expand, the compounds appeared to weaken their structural organization, limiting the ability to establish new growth sites.

Scientists stress that these effects were observed in controlled lab environments, not in human patients. Still, the results open an important avenue for research. Slowing or interrupting cancer spread could one day improve outcomes when combined with conventional treatments like chemotherapy or targeted therapies.

Researchers caution that this is not a cure and not a replacement for medical treatment. However, the study highlights how plant-derived compounds may one day support cancer therapy by targeting mechanisms that traditional drugs often struggle to address.

As science continues exploring the complex relationship between cannabinoids and cancer biology, studies like this reinforce the importance of evidence-based research over assumptions or hype. The story is still unfolding—and it’s one worth watching.

Reference: ScienceDaily, Medical Cannabis Research

12/31/2025

A top Trump administration health official said last week that his agency will soon launch a novel program to have Medicare cover the costs of CBD for certain patients. But while the administration has not yet released specific details about the initiative’s rollout, one cannabis company that says...

12/25/2025

🌿 Cannabis & H**p CBD in Cancer Care: A New Frontier in Healing 🌿

Cancer affects every person differently — and so do the ways people cope, heal, and find comfort along the journey. Many patients around the world are integrating supportive therapies like cannabis and hemp-derived CBD alongside conventional care to help manage symptoms such as pain, nausea, sleep disruption, anxiety, and appetite changes.

Ongoing research is helping us better understand how cannabinoids interact with the body’s endocannabinoid system and the role they may play in improving quality of life during cancer care.

📖 Want to learn more about the science behind the ECS and the research surrounding cannabis in cancer care? Read the blog—check the links in the comment section! 💚

12/25/2025

Dew Drops wants to thank family, friends and clients for all your amazing support, and I pray you and your families have a wonderful Christmas. And a safe, healthy and Blessed New Year!!

Remember the best investment is your health!!!!

Stay tune for 2026. We have some gig changes and new name!!!

Merry
Christmas!!

12/25/2025

On Dec. 18, 2025, President Donald Trump signed an executive order titled Increasing Medical Ma*****na and Cannabidiol Research, directing the Department of Justice to reschedule ma*****na under the Controlled Substances Act (CSA).

This reclassification reflects growing scientific evidence of ma*****na’s medical utility.

(..continued below)

12/25/2025

A Democratic senator has filed a bill aimed at laying the groundwork for federal ma*****na legalization. Sen. John Hickenlooper (D-CO) introduced the legislation—titled the Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment Act (PREPARE) Act—on Thursday. The ...